TIDMFUM
RNS Number : 5589M
Futura Medical PLC
12 January 2023
12 January 2023
Futura Medical plc
("Futura" or the "Company")
Remuneration of Non-Executive Directors, Grant of Options and
Total Voting Rights
Futura Medical plc (AIM: FUM), a pharmaceutical company
developing a portfolio of innovative products based on its
proprietary, transdermal DermaSys(R) drug delivery technology and
currently focused on sexual health and pain, announces the issue of
87,430 new ordinary shares of 0.2 pence each ("Ordinary Shares") in
respect of the 2022 remuneration of its Non-Executive Directors and
a grant of 4,444,942 options over Ordinary Shares ("Options") to
employees and Directors.
Remuneration of Non-Executive Directors
In accordance with the terms of their service agreements, the
Non-Executive Directors receive 25-30 per cent of their
remuneration in the form of Ordinary Shares. For 2022, these were
issued at 36.36 pence per share, being the average closing
mid-market price of the last 10 trading days of 2021 (as announced
via RNS on 13 January 2022).
The 87,430 new Ordinary Shares shall rank pari passu with the
existing issued Ordinary Shares of the Company and have been issued
as follows:
Director Number of Ordinary Shares issued Total number of ordinary shares Percentage of the Company's
for 2022 remuneration held resulting issued share capital
John Clarke 44,560 795,100 0.28%
Jeff Needham 16,344 16,344 0.01%
Andrew Unitt 26,526 26,526 0.01%
The shares element of the Non-Executive Directors' remuneration
for 2023 will be awarded at 51.50 pence per Ordinary Share, being
the average closing mid-market price of the last 10 trading days of
2022. The Non-Executive Directors will receive these shares in
January 2024.
Grant of Options
The Company has granted a total of 4,444,942 Options of which
1,985,626 have been awarded to Directors as detailed below.
All Options have been granted under existing schemes and vest
equally over 3 years to January 2025 with 25% of the Options
granted with immediate vesting. The main condition is that the
individual remains an employee or Director at the time of
vesting.
Director Number of Options granted Exercise price Total number of Options held following grant
James Barder 540,716 0.2p 2,085,716
Angela Hildreth 472,340 0.2p 1,508,340
John Clarke 463,343 0.2p 463,343
Ken James 509,227 0.2p 1,945,227
Total Voting Rights
Application has been made to the London Stock Exchange and it is
anticipated that trading of the new Ordinary Shares will commence
on AIM at 8:00am on 17 January 2023.
Immediately following the above issue, the Company will have
288,133,957 ordinary shares in issue, each carrying one voting
right. Since the Company currently holds no shares in treasury, the
total number of voting rights in the Company is therefore
288,133,957 and this figure may be used by Shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's
Disclosure Guidance and Transparency Rules.
Further details are contained within the notifications below,
made in accordance with Article 19 of the EU Market Abuse
Regulation 596/2014. Full details of the Non-Executive Directors'
remuneration will be included in the Company's Annual Report &
Accounts.
S
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Angela Hildreth, Finance Director and COO
Email: investor.relations@futuramedical.com
Tel: +44 (0) 1483 685 670
www.futuramedical.com
Nominated Adviser and Sole Broker:
Liberum
Phil Walker/ Richard Lindley/ Ben Cryer/ Kane Collings
Tel: +44 (0) 20 3100 2000
For media enquiries please contact:
Optimum Strategic Communications
Mary Clark/ Eva Haas/ Hollie Vile/ Zoe Bolt
Email: futuramedical@optimumcomms.com
Tel: +44 (0) 203 882 9621
About Futura Medical plc
Futura Medical plc (AIM: FUM), is a pharmaceutical company
developing a portfolio of innovative products based on its
proprietary, transdermal DermaSys(R) technology. Each DermaSys(R)
formulation is separately patented and specifically tailored for
the selected indication and application, as well as being optimised
for clinical efficacy, safety, administration and patient
convenience. The products are developed for the prescription and
consumer healthcare markets as appropriate. Current therapeutic
areas are sexual health, including erectile dysfunction, and pain
relief. Development and commercialisation strategies are designed
to maximise product differentiation and value creation whilst
minimising risk.
MED3000 is Futura's topical gel formulation that is a
breakthrough treatment for erectile dysfunction ("ED") through a
unique evaporative mode of action. Futura has previously conducted
a Phase 3 study using MED3000 in ED, referred to as "FM57". This
was a 1,000 patient, dose-ranging, multi-centre, randomised, double
blind, placebo-controlled, home use, parallel group study
delivering highly statistically significant results compared to
pre-treatment baseline, using measures IIEF-EF, SEP2 and SEP3
(internationally accepted clinical trial endpoints in ED) with over
60% of patients experiencing a clinically meaningful improvement in
their ED.
MED3000 is CE marked in Europe and CA marked in the UK as a
clinically proven topical treatment for adult men with erectile
dysfunction under the brand Eroxon(TM) with a key claim of "Helps
you get an erection within 10 minutes".
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name John Clarke
------------------------------ -----------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Director/ PDMR
------------------------------ -----------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ -----------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
------------------------------ -----------------------------------
b) LEI 21380053QLT46UNV2303
------------------------------ -----------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Ordinary shares of 0.2p each
type of instrument
GB0033278473
Identification code
------------------------------ -----------------------------------
b) Nature of the transaction Issue of shares
------------------------------ -----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
36.36 pence 44,560
----------
------------------------------ -----------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
------------------------------ -----------------------------------
e) Date of the transaction 11 January 2023
------------------------------ -----------------------------------
f) Place of the transaction Outside of trading venue
------------------------------ -----------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Jeff Needham
------------------------------ -----------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Director/ PDMR
------------------------------ -----------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ -----------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
------------------------------ -----------------------------------
b) LEI 21380053QLT46UNV2303
------------------------------ -----------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Ordinary shares of 0.2p each
type of instrument
GB0033278473
Identification code
------------------------------ -----------------------------------
b) Nature of the transaction Issue of shares
------------------------------ -----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
36.36 pence 16,344
----------
------------------------------ -----------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
------------------------------ -----------------------------------
e) Date of the transaction 11 January 2023
------------------------------ -----------------------------------
f) Place of the transaction Outside of trading venue
------------------------------ -----------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Andrew Unitt
------------------------------ -----------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Director/ PDMR
------------------------------ -----------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ -----------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
------------------------------ -----------------------------------
b) LEI 21380053QLT46UNV2303
------------------------------ -----------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Ordinary shares of 0.2p each
type of instrument
GB0033278473
Identification code
------------------------------ -----------------------------------
b) Nature of the transaction Issue of shares
------------------------------ -----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
36.36 pence 26,526
----------
------------------------------ -----------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
------------------------------ -----------------------------------
e) Date of the transaction 11 January 2023
------------------------------ -----------------------------------
f) Place of the transaction Outside of trading venue
------------------------------ -----------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name James Barder
-------------------------- ---------------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Director/ PDMR
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
-------------------------- ---------------------------------------
b) LEI 21380053QLT46UNV2303
-------------------------- ---------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Options over Ordinary shares of 0.2p
type of instrument each
Identification code GB0033278473
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of Options over Ordinary Shares
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
nil 540,716
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
-------------------------- ---------------------------------------
e) Date of the transaction 10 January 2023
-------------------------- ---------------------------------------
f) Place of the transaction Outside of trading venue
-------------------------- ---------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Angela Hildreth
-------------------------- ---------------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Director/ PDMR
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
-------------------------- ---------------------------------------
b) LEI 21380053QLT46UNV2303
-------------------------- ---------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Options over Ordinary shares of 0.2p
type of instrument each
Identification code GB0033278473
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of Options over Ordinary Shares
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
nil 472,340
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
-------------------------- ---------------------------------------
e) Date of the transaction 10 January 2023
-------------------------- ---------------------------------------
f) Place of the transaction Outside of trading venue
-------------------------- ---------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name John Clarke
-------------------------- ---------------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Director/ PDMR
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
-------------------------- ---------------------------------------
b) LEI 21380053QLT46UNV2303
-------------------------- ---------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Options over Ordinary shares of 0.2p
type of instrument each
Identification code GB0033278473
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of Options over Ordinary Shares
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
nil 463,343
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
-------------------------- ---------------------------------------
e) Date of the transaction 10 January 2023
-------------------------- ---------------------------------------
f) Place of the transaction Outside of trading venue
-------------------------- ---------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Ken James
-------------------------- ---------------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Director/ PDMR
-------------------------- ---------------------------------------
b) Initial notification Initial notification
/Amendment
-------------------------- ---------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
-------------------------- ---------------------------------------
b) LEI 21380053QLT46UNV2303
-------------------------- ---------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Options over Ordinary shares of 0.2p
type of instrument each
Identification code GB0033278473
-------------------------- ---------------------------------------
b) Nature of the transaction Grant of Options over Ordinary Shares
-------------------------- ---------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
nil 509,227
----------
-------------------------- ---------------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
-------------------------- ---------------------------------------
e) Date of the transaction 10 January 2023
-------------------------- ---------------------------------------
f) Place of the transaction Outside of trading venue
-------------------------- ---------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHGPUCUGUPWGGP
(END) Dow Jones Newswires
January 12, 2023 06:09 ET (11:09 GMT)
Futura Medical (LSE:FUM)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Futura Medical (LSE:FUM)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024